| 000 | 00000nam 2200000za 4500 |
| 001 | 9.848148 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107153614 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 171201s2018 onca o f000 0 eng d |
|---|
| 020 | |a9780660240817|z9780660240824 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aNR16-187/2017E-PDF |
|---|
| 110 | 2 |aNational Research Council Canada. |
|---|
| 245 | 10|aCell culture pilot plant |h[electronic resource]. |
|---|
| 260 | |a[Ottawa] : |bNational Research Council Canada, |c2018. |
|---|
| 300 | |a[2] p. : |bcol. ill. |
|---|
| 500 | |aIssued also in French under title: Usine pilote, culture cellulaire. |
|---|
| 500 | |aCaption title. |
|---|
| 500 | |a"January 2018." |
|---|
| 520 | |a"Our team of cell biologists, purification experts and biochemical engineers have extensive experience in process optimization and scale-up, cell culture in bioreactors, medium development, viral infection processes, recovery and purification, and HPLC and cell-based assays. Our medium development specialists enable you to optimize culture media and develop feeding strategies to improve product yield. We excel at working with monitoring tools to develop control strategies. Our tailored analytical assays ensure a smooth transition from bench-scale process optimization all the way up to production at the 500 L pilot scale"--P. [1]. |
|---|
| 530 | |aIssued also in print format. |
|---|
| 693 | 4|aCell culture |
|---|
| 693 | 4|aPharmaceutical biotechnology |
|---|
| 775 | 08|tUsine pilote, culture cellulaire |w(CaOODSP)9.848150 |
|---|
| 776 | 0#|tCell culture pilot plant |w(CaOODSP)9.848149 |
|---|
| 856 | 40|qPDF|s153 KB|uhttps://publications.gc.ca/collections/collection_2018/cnrc-nrc/NR16-187-2017-eng.pdf |
|---|